What has been achieved in HIV prevention, treatment and care for people who inject drugs, 2010-2012? A review of the six highest burden countries.
Identifieur interne : 003926 ( PubMed/Curation ); précédent : 003925; suivant : 003927What has been achieved in HIV prevention, treatment and care for people who inject drugs, 2010-2012? A review of the six highest burden countries.
Auteurs : Louisa Degenhardt [Australie] ; Bradley M. Mathers [Australie] ; Andrea L. Wirtz [États-Unis] ; Daniel Wolfe [États-Unis] ; Adeeba Kamarulzaman [Malaisie] ; M Patrizia Carrieri [France] ; Steffanie A. Strathdee [États-Unis] ; Kasia Malinowska-Sempruch [Pologne] ; Michel Kazatchkine [Suisse] ; Chris Beyrer [États-Unis]Source :
- The International journal on drug policy [ 1873-4758 ] ; 2014.
Descripteurs français
- KwdFr :
- Antirétroviraux (usage thérapeutique), Chine, Humains, Infections à VIH (), Infections à VIH (traitement médicamenteux), Malaisie, Politique de santé, Programme d'échange de seringues (tendances), Russie, Toxicomanie intraveineuse (), Toxicomanie intraveineuse (traitement médicamenteux), Traitement de substitution aux opiacés (tendances), Ukraine, Vietnam, États-Unis d'Amérique.
- MESH :
- tendances : Programme d'échange de seringues, Traitement de substitution aux opiacés.
- traitement médicamenteux : Infections à VIH, Toxicomanie intraveineuse.
- usage thérapeutique : Antirétroviraux.
- Chine, Humains, Infections à VIH, Malaisie, Politique de santé, Russie, Toxicomanie intraveineuse, Ukraine, Vietnam, États-Unis d'Amérique.
- Wicri :
- geographic : République populaire de Chine, Malaisie, Ukraine, États-Unis.
English descriptors
- KwdEn :
- Anti-Retroviral Agents (therapeutic use), China, HIV Infections (complications), HIV Infections (drug therapy), HIV Infections (prevention & control), Health Policy, Humans, Malaysia, Needle-Exchange Programs (trends), Opiate Substitution Treatment (trends), Russia, Substance Abuse, Intravenous (complications), Substance Abuse, Intravenous (drug therapy), Ukraine, United States, Vietnam.
- MESH :
- chemical , therapeutic use : Anti-Retroviral Agents.
- geographic : China, Malaysia, Russia, Ukraine, United States, Vietnam.
- complications : HIV Infections, Substance Abuse, Intravenous.
- drug therapy : HIV Infections, Substance Abuse, Intravenous.
- prevention & control : HIV Infections.
- trends : Needle-Exchange Programs, Opiate Substitution Treatment.
- Health Policy, Humans.
Abstract
In 2010 the international HIV/AIDS community called on countries to take action to prevent HIV transmission among people who inject drugs (PWID). To set a baseline we proposed an "accountability matrix", focusing upon six countries accounting for half of the global population of PWID: China, Malaysia, Russia, Ukraine, Vietnam and the USA. Two years on, we review progress.
DOI: 10.1016/j.drugpo.2013.08.004
PubMed: 24113623
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :003A55
Links to Exploration step
pubmed:24113623Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">What has been achieved in HIV prevention, treatment and care for people who inject drugs, 2010-2012? A review of the six highest burden countries.</title><author><name sortKey="Degenhardt, Louisa" sort="Degenhardt, Louisa" uniqKey="Degenhardt L" first="Louisa" last="Degenhardt">Louisa Degenhardt</name><affiliation wicri:level="1"><nlm:affiliation>National Drug and Alcohol Research Centre, University of New South Wales, Sydney, New South Wales, Australia; School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia. Electronic address: L.Degenhardt@unsw.edu.au.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>National Drug and Alcohol Research Centre, University of New South Wales, Sydney, New South Wales, Australia; School of Population and Global Health, University of Melbourne, Melbourne, Victoria</wicri:regionArea></affiliation></author><author><name sortKey="Mathers, Bradley M" sort="Mathers, Bradley M" uniqKey="Mathers B" first="Bradley M" last="Mathers">Bradley M. Mathers</name><affiliation wicri:level="1"><nlm:affiliation>Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Kirby Institute, University of New South Wales, Sydney, New South Wales</wicri:regionArea></affiliation></author><author><name sortKey="Wirtz, Andrea L" sort="Wirtz, Andrea L" uniqKey="Wirtz A" first="Andrea L" last="Wirtz">Andrea L. Wirtz</name><affiliation wicri:level="1"><nlm:affiliation>Center for Public Health and Human Rights, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Center for Public Health and Human Rights, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD</wicri:regionArea></affiliation></author><author><name sortKey="Wolfe, Daniel" sort="Wolfe, Daniel" uniqKey="Wolfe D" first="Daniel" last="Wolfe">Daniel Wolfe</name><affiliation wicri:level="1"><nlm:affiliation>International Harm Reduction Development Program, Open Society Foundations, New York, NY, United States.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>International Harm Reduction Development Program, Open Society Foundations, New York, NY</wicri:regionArea></affiliation></author><author><name sortKey="Kamarulzaman, Adeeba" sort="Kamarulzaman, Adeeba" uniqKey="Kamarulzaman A" first="Adeeba" last="Kamarulzaman">Adeeba Kamarulzaman</name><affiliation wicri:level="1"><nlm:affiliation>Centre of Excellence for Research in AIDS (CERiA), Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.</nlm:affiliation><country xml:lang="fr">Malaisie</country><wicri:regionArea>Centre of Excellence for Research in AIDS (CERiA), Faculty of Medicine, University of Malaya, Kuala Lumpur</wicri:regionArea></affiliation></author><author><name sortKey="Carrieri, M Patrizia" sort="Carrieri, M Patrizia" uniqKey="Carrieri M" first="M Patrizia" last="Carrieri">M Patrizia Carrieri</name><affiliation wicri:level="1"><nlm:affiliation>INSERM, U912 (SESSTIM), Marseille, France; Université Aix Marseille, IRD, UMR-S912, Marseille, France; ORS PACA, Observatoire Régional de la Santé Provence Alpes Côte d'Azur, Marseille, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>INSERM, U912 (SESSTIM), Marseille, France; Université Aix Marseille, IRD, UMR-S912, Marseille, France; ORS PACA, Observatoire Régional de la Santé Provence Alpes Côte d'Azur, Marseille</wicri:regionArea></affiliation></author><author><name sortKey="Strathdee, Steffanie A" sort="Strathdee, Steffanie A" uniqKey="Strathdee S" first="Steffanie A" last="Strathdee">Steffanie A. Strathdee</name><affiliation wicri:level="1"><nlm:affiliation>University of California, San Diego, Division of Global Public Health, Department of Medicine, United States.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>University of California, San Diego, Division of Global Public Health, Department of Medicine</wicri:regionArea></affiliation></author><author><name sortKey="Malinowska Sempruch, Kasia" sort="Malinowska Sempruch, Kasia" uniqKey="Malinowska Sempruch K" first="Kasia" last="Malinowska-Sempruch">Kasia Malinowska-Sempruch</name><affiliation wicri:level="1"><nlm:affiliation>Global Drug Policy Program, Open Society Foundations, Warsaw, Poland.</nlm:affiliation><country xml:lang="fr">Pologne</country><wicri:regionArea>Global Drug Policy Program, Open Society Foundations, Warsaw</wicri:regionArea></affiliation></author><author><name sortKey="Kazatchkine, Michel" sort="Kazatchkine, Michel" uniqKey="Kazatchkine M" first="Michel" last="Kazatchkine">Michel Kazatchkine</name><affiliation wicri:level="1"><nlm:affiliation>UN Secretary-General special Envoy on HIV/AIDS in Eastern Europe and Central Asia, Geneva, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>UN Secretary-General special Envoy on HIV/AIDS in Eastern Europe and Central Asia, Geneva</wicri:regionArea></affiliation></author><author><name sortKey="Beyrer, Chris" sort="Beyrer, Chris" uniqKey="Beyrer C" first="Chris" last="Beyrer">Chris Beyrer</name><affiliation wicri:level="1"><nlm:affiliation>Center for Public Health and Human Rights, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Center for Public Health and Human Rights, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2014">2014</date><idno type="RBID">pubmed:24113623</idno><idno type="pmid">24113623</idno><idno type="doi">10.1016/j.drugpo.2013.08.004</idno><idno type="wicri:Area/PubMed/Corpus">003A55</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003A55</idno><idno type="wicri:Area/PubMed/Curation">003926</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003926</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">What has been achieved in HIV prevention, treatment and care for people who inject drugs, 2010-2012? A review of the six highest burden countries.</title><author><name sortKey="Degenhardt, Louisa" sort="Degenhardt, Louisa" uniqKey="Degenhardt L" first="Louisa" last="Degenhardt">Louisa Degenhardt</name><affiliation wicri:level="1"><nlm:affiliation>National Drug and Alcohol Research Centre, University of New South Wales, Sydney, New South Wales, Australia; School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia. Electronic address: L.Degenhardt@unsw.edu.au.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>National Drug and Alcohol Research Centre, University of New South Wales, Sydney, New South Wales, Australia; School of Population and Global Health, University of Melbourne, Melbourne, Victoria</wicri:regionArea></affiliation></author><author><name sortKey="Mathers, Bradley M" sort="Mathers, Bradley M" uniqKey="Mathers B" first="Bradley M" last="Mathers">Bradley M. Mathers</name><affiliation wicri:level="1"><nlm:affiliation>Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Kirby Institute, University of New South Wales, Sydney, New South Wales</wicri:regionArea></affiliation></author><author><name sortKey="Wirtz, Andrea L" sort="Wirtz, Andrea L" uniqKey="Wirtz A" first="Andrea L" last="Wirtz">Andrea L. Wirtz</name><affiliation wicri:level="1"><nlm:affiliation>Center for Public Health and Human Rights, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Center for Public Health and Human Rights, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD</wicri:regionArea></affiliation></author><author><name sortKey="Wolfe, Daniel" sort="Wolfe, Daniel" uniqKey="Wolfe D" first="Daniel" last="Wolfe">Daniel Wolfe</name><affiliation wicri:level="1"><nlm:affiliation>International Harm Reduction Development Program, Open Society Foundations, New York, NY, United States.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>International Harm Reduction Development Program, Open Society Foundations, New York, NY</wicri:regionArea></affiliation></author><author><name sortKey="Kamarulzaman, Adeeba" sort="Kamarulzaman, Adeeba" uniqKey="Kamarulzaman A" first="Adeeba" last="Kamarulzaman">Adeeba Kamarulzaman</name><affiliation wicri:level="1"><nlm:affiliation>Centre of Excellence for Research in AIDS (CERiA), Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.</nlm:affiliation><country xml:lang="fr">Malaisie</country><wicri:regionArea>Centre of Excellence for Research in AIDS (CERiA), Faculty of Medicine, University of Malaya, Kuala Lumpur</wicri:regionArea></affiliation></author><author><name sortKey="Carrieri, M Patrizia" sort="Carrieri, M Patrizia" uniqKey="Carrieri M" first="M Patrizia" last="Carrieri">M Patrizia Carrieri</name><affiliation wicri:level="1"><nlm:affiliation>INSERM, U912 (SESSTIM), Marseille, France; Université Aix Marseille, IRD, UMR-S912, Marseille, France; ORS PACA, Observatoire Régional de la Santé Provence Alpes Côte d'Azur, Marseille, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>INSERM, U912 (SESSTIM), Marseille, France; Université Aix Marseille, IRD, UMR-S912, Marseille, France; ORS PACA, Observatoire Régional de la Santé Provence Alpes Côte d'Azur, Marseille</wicri:regionArea></affiliation></author><author><name sortKey="Strathdee, Steffanie A" sort="Strathdee, Steffanie A" uniqKey="Strathdee S" first="Steffanie A" last="Strathdee">Steffanie A. Strathdee</name><affiliation wicri:level="1"><nlm:affiliation>University of California, San Diego, Division of Global Public Health, Department of Medicine, United States.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>University of California, San Diego, Division of Global Public Health, Department of Medicine</wicri:regionArea></affiliation></author><author><name sortKey="Malinowska Sempruch, Kasia" sort="Malinowska Sempruch, Kasia" uniqKey="Malinowska Sempruch K" first="Kasia" last="Malinowska-Sempruch">Kasia Malinowska-Sempruch</name><affiliation wicri:level="1"><nlm:affiliation>Global Drug Policy Program, Open Society Foundations, Warsaw, Poland.</nlm:affiliation><country xml:lang="fr">Pologne</country><wicri:regionArea>Global Drug Policy Program, Open Society Foundations, Warsaw</wicri:regionArea></affiliation></author><author><name sortKey="Kazatchkine, Michel" sort="Kazatchkine, Michel" uniqKey="Kazatchkine M" first="Michel" last="Kazatchkine">Michel Kazatchkine</name><affiliation wicri:level="1"><nlm:affiliation>UN Secretary-General special Envoy on HIV/AIDS in Eastern Europe and Central Asia, Geneva, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>UN Secretary-General special Envoy on HIV/AIDS in Eastern Europe and Central Asia, Geneva</wicri:regionArea></affiliation></author><author><name sortKey="Beyrer, Chris" sort="Beyrer, Chris" uniqKey="Beyrer C" first="Chris" last="Beyrer">Chris Beyrer</name><affiliation wicri:level="1"><nlm:affiliation>Center for Public Health and Human Rights, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Center for Public Health and Human Rights, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD</wicri:regionArea></affiliation></author></analytic><series><title level="j">The International journal on drug policy</title><idno type="eISSN">1873-4758</idno><imprint><date when="2014" type="published">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Anti-Retroviral Agents (therapeutic use)</term><term>China</term><term>HIV Infections (complications)</term><term>HIV Infections (drug therapy)</term><term>HIV Infections (prevention & control)</term><term>Health Policy</term><term>Humans</term><term>Malaysia</term><term>Needle-Exchange Programs (trends)</term><term>Opiate Substitution Treatment (trends)</term><term>Russia</term><term>Substance Abuse, Intravenous (complications)</term><term>Substance Abuse, Intravenous (drug therapy)</term><term>Ukraine</term><term>United States</term><term>Vietnam</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Antirétroviraux (usage thérapeutique)</term><term>Chine</term><term>Humains</term><term>Infections à VIH ()</term><term>Infections à VIH (traitement médicamenteux)</term><term>Malaisie</term><term>Politique de santé</term><term>Programme d'échange de seringues (tendances)</term><term>Russie</term><term>Toxicomanie intraveineuse ()</term><term>Toxicomanie intraveineuse (traitement médicamenteux)</term><term>Traitement de substitution aux opiacés (tendances)</term><term>Ukraine</term><term>Vietnam</term><term>États-Unis d'Amérique</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-Retroviral Agents</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>China</term><term>Malaysia</term><term>Russia</term><term>Ukraine</term><term>United States</term><term>Vietnam</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>HIV Infections</term><term>Substance Abuse, Intravenous</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>HIV Infections</term><term>Substance Abuse, Intravenous</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>HIV Infections</term></keywords><keywords scheme="MESH" qualifier="tendances" xml:lang="fr"><term>Programme d'échange de seringues</term><term>Traitement de substitution aux opiacés</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Infections à VIH</term><term>Toxicomanie intraveineuse</term></keywords><keywords scheme="MESH" qualifier="trends" xml:lang="en"><term>Needle-Exchange Programs</term><term>Opiate Substitution Treatment</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antirétroviraux</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Health Policy</term><term>Humans</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Chine</term><term>Humains</term><term>Infections à VIH</term><term>Malaisie</term><term>Politique de santé</term><term>Russie</term><term>Toxicomanie intraveineuse</term><term>Ukraine</term><term>Vietnam</term><term>États-Unis d'Amérique</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>République populaire de Chine</term><term>Malaisie</term><term>Ukraine</term><term>États-Unis</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">In 2010 the international HIV/AIDS community called on countries to take action to prevent HIV transmission among people who inject drugs (PWID). To set a baseline we proposed an "accountability matrix", focusing upon six countries accounting for half of the global population of PWID: China, Malaysia, Russia, Ukraine, Vietnam and the USA. Two years on, we review progress.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24113623</PMID><DateCreated><Year>2014</Year><Month>01</Month><Day>29</Day></DateCreated><DateCompleted><Year>2014</Year><Month>11</Month><Day>18</Day></DateCompleted><DateRevised><Year>2014</Year><Month>01</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-4758</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>1</Issue><PubDate><Year>2014</Year><Month>Jan</Month></PubDate></JournalIssue><Title>The International journal on drug policy</Title><ISOAbbreviation>Int. J. Drug Policy</ISOAbbreviation></Journal><ArticleTitle>What has been achieved in HIV prevention, treatment and care for people who inject drugs, 2010-2012? A review of the six highest burden countries.</ArticleTitle><Pagination><MedlinePgn>53-60</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.drugpo.2013.08.004</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0955-3959(13)00128-X</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">In 2010 the international HIV/AIDS community called on countries to take action to prevent HIV transmission among people who inject drugs (PWID). To set a baseline we proposed an "accountability matrix", focusing upon six countries accounting for half of the global population of PWID: China, Malaysia, Russia, Ukraine, Vietnam and the USA. Two years on, we review progress.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">We searched peer-reviewed literature, conducted online searches, and contacted experts for 'grey' literature. We limited searches to documents published since December 2009 and used decision rules endorsed in earlier reviews.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Policy shifts are increasing coverage of key interventions for PWID in China, Malaysia, Vietnam and Ukraine. Increases in PWID receiving antiretroviral treatment (ART) and opioid substitution treatment (OST) in both Vietnam and China, and a shift in Malaysia from a punitive law enforcement approach to evidence-based treatment are promising developments. The USA and Russia have had no advances on PWID access to needle and syringe programmes (NSP), OST or ART. There have also been policy setbacks in these countries, with Russia reaffirming its stance against OST and closing down access to information on methadone, and the USA reinstituting its Congressional ban on Federal funding for NSPs.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Prevention of HIV infection and access to HIV treatment for PWID is possible. Whether countries with concentrated epidemics among PWID will meet goals of achieving universal access and eliminating new HIV infections remains unknown. As long as law enforcement responses counter public health responses, health-seeking behaviour and health service delivery will be limited.</AbstractText><CopyrightInformation>Copyright © 2013 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Degenhardt</LastName><ForeName>Louisa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>National Drug and Alcohol Research Centre, University of New South Wales, Sydney, New South Wales, Australia; School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia. Electronic address: L.Degenhardt@unsw.edu.au.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mathers</LastName><ForeName>Bradley M</ForeName><Initials>BM</Initials><AffiliationInfo><Affiliation>Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wirtz</LastName><ForeName>Andrea L</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Center for Public Health and Human Rights, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wolfe</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>International Harm Reduction Development Program, Open Society Foundations, New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kamarulzaman</LastName><ForeName>Adeeba</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre of Excellence for Research in AIDS (CERiA), Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carrieri</LastName><ForeName>M Patrizia</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>INSERM, U912 (SESSTIM), Marseille, France; Université Aix Marseille, IRD, UMR-S912, Marseille, France; ORS PACA, Observatoire Régional de la Santé Provence Alpes Côte d'Azur, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Strathdee</LastName><ForeName>Steffanie A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>University of California, San Diego, Division of Global Public Health, Department of Medicine, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malinowska-Sempruch</LastName><ForeName>Kasia</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Global Drug Policy Program, Open Society Foundations, Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kazatchkine</LastName><ForeName>Michel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>UN Secretary-General special Envoy on HIV/AIDS in Eastern Europe and Central Asia, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beyrer</LastName><ForeName>Chris</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Center for Public Health and Human Rights, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>09</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Int J Drug Policy</MedlineTA><NlmUniqueID>9014759</NlmUniqueID><ISSNLinking>0955-3959</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D044966">Anti-Retroviral Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D044966" MajorTopicYN="N">Anti-Retroviral Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006291" MajorTopicYN="Y">Health Policy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008296" MajorTopicYN="N" Type="Geographic">Malaysia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018671" MajorTopicYN="N">Needle-Exchange Programs</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058850" MajorTopicYN="N">Opiate Substitution Treatment</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012426" MajorTopicYN="N" Type="Geographic">Russia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015819" MajorTopicYN="N">Substance Abuse, Intravenous</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014455" MajorTopicYN="N" Type="Geographic">Ukraine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014744" MajorTopicYN="N" Type="Geographic">Vietnam</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Injecting drug use, HIV, Needle and syringe programme</Keyword><Keyword MajorTopicYN="N">Opioid substitution therapy, Antiretroviral therapy, Prevention</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>01</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2013</Year><Month>08</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>08</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>10</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>10</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>11</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24113623</ArticleId><ArticleId IdType="pii">S0955-3959(13)00128-X</ArticleId><ArticleId IdType="doi">10.1016/j.drugpo.2013.08.004</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003926 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 003926 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:24113623
|texte= What has been achieved in HIV prevention, treatment and care for people who inject drugs, 2010-2012? A review of the six highest burden countries.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:24113623" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |